Squarepoint Ops LLC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 86 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,077,538
-77.1%
26,243
-75.9%
0.00%
-75.0%
Q1 2024$4,712,354
+567.8%
108,755
+608.5%
0.01%
+700.0%
Q4 2023$705,640
-62.7%
15,350
-85.5%
0.00%
-87.5%
Q1 2023$1,890,594
-0.3%
105,975
+62.7%
0.01%
+14.3%
Q4 2022$1,896,819
+33.5%
65,138
+12.3%
0.01%0.0%
Q3 2022$1,421,000
+676.5%
57,994
+31.3%
0.01%
+600.0%
Q2 2022$183,000
+8.9%
44,164
+203.3%
0.00%0.0%
Q1 2022$168,000
-58.4%
14,562
-29.3%
0.00%
-50.0%
Q2 2021$404,000
-73.5%
20,611
-71.2%
0.00%
-77.8%
Q1 2021$1,522,000
+1.7%
71,544
+42.1%
0.01%
-18.2%
Q4 2020$1,497,000
+574.3%
50,341
+391.7%
0.01%
+266.7%
Q3 2020$222,000
-73.2%
10,239
-71.6%
0.00%
-40.0%
Q4 2019$828,000
+70.4%
36,077
+60.2%
0.01%
+25.0%
Q3 2019$486,000
-31.6%
22,515
-13.2%
0.00%
-50.0%
Q1 2019$711,000
-15.6%
25,945
-17.2%
0.01%
-20.0%
Q4 2018$842,000
-11.9%
31,337
-4.4%
0.01%
-9.1%
Q3 2018$956,000
+60.9%
32,763
+72.5%
0.01%
+37.5%
Q2 2018$594,00018,9930.01%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Opaleye Management Inc. 735,000$13,112,4003.93%
NEA Management Company, LLC 2,909,956$51,913,6153.59%
Frazier Life Sciences Management, L.P. 2,164,739$38,618,9442.80%
RA Capital Management 5,516,067$98,406,6352.23%
Samsara BioCapital, LLC 345,293$6,160,0271.27%
Rock Springs Capital Management LP 1,597,123$28,492,6740.68%
Baker Brothers Advisors 6,498,267$115,929,0830.63%
HighVista Strategies LLC 35,478$632,9280.52%
Nan Fung Group Holdings Ltd 32,520$580,1570.40%
GREAT POINT PARTNERS LLC 97,544$1,740,1850.34%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders